Curran Terrie 4
4 · Phathom Pharmaceuticals, Inc. · Filed Mar 3, 2025
Insider Transaction Report
Form 4
Curran Terrie
DirectorPresident and Chief Executive
Transactions
- Award
Stock Option (Right to Buy)
2025-02-27+342,500→ 342,500 totalExercise: $5.76Exp: 2035-02-26→ Common Stock (342,500 underlying)
Footnotes (1)
- [F1]The stock option will vest with respect to 25% of the shares of common stock on February 27, 2026, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the reporting person's continuous service to the Company on the applicable vesting dates.